Clinical Trials on Information Disclosure in India
Total 0 results
Nothing found
Sponsors and Collaborators
- Universitatea de Medicina si Farmacie Iuliu Hatieganu
- The Fred Hollows Foundation, Australia
- JMI Laboratories
- Hospital Samaritano Paulista
- Prof. Jacques SCHRENZEL
- Markham Stouffville Hospital
- Pedro Gamito
- UZ Leuven, campus Pellenberg (Belgium)
- Advanced Life Solutions
- IN-JET APS
- Familien Hede Nielsens Fond
- Custom Pharmaceuticals Limited
- Fogarty International Center of the National Institute of Health
- Braunschweig Integrated Centre of Systems Biology (BRICS), Germany
- Hazelden Betty Ford Foundation
- Physip S.A
- Janssen (China) Research & Development Center
- Stannah Stairlifts
- Nestlé Health Science Belgium
- Dr. Praveen B.H
- View Full List
Medical Conditions
- Chlamydophila Infections
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- Painless Hysteroscopy
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Psoriasis, Arthritic
- Tay-Sachs Disease Ganglioside
- Endocarditis Infective
- Fracture Dislocation of Cervical Spine
- Epidemic Hemorrhagic Fever
- Gullian Barre Syndrome
- Ewing's Family Tumors
- Multisystem Proteinopathy
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Pulmonary Adenocarcinoma
- Spine Surgeries
- Fetus or Neonate Affected by External Version Before Labor
- Childhood Langerhans Cell Histiocytosis
- Closure; Foramen Ovale
- Skull Base Neoplasms
- Predictors of Atrial Fibrillation Recurrences
- View Full List
Drug Interventions
- Palliative care group first-line scheme
- Estradiol+Drospirenone
- Adriamycin
- Chemotherapeutic Agent
- Azelastine hydrochloride (BAYR9258)
- Redifferentiation with retinoid acid
- Esomeprazole 40mg before
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- Adapalene Gel 0.3%
- Neihulizumab
- Vehicle
- Qingkailing injection 40 ml
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- High dose pantoprazole infusion
- Semapimod
- Cereport
- Glimepiride
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- EFV +TVA
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- View Full List
CROs by country
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Benin
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Colombia
- Contract Research Organizations in Ethiopia
- Contract Research Organizations in Italy
- Contract Research Organizations in Jordan
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Mongolia
- Contract Research Organizations in Romania
- Contract Research Organizations in Rwanda
- Contract Research Organizations in Singapore
- Contract Research Organizations in Ukraine
- CRO list by country